SCHEMBL24850641

SCHEMBL24850641

Cc1ccc(C#Cc2ccccc2)nc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 10/20 0.59
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
KDM4E B2RXH2 1/20 0.59
MEN1 O00255 1/20 0.59
ALDH1A1 P00352 1/20 0.59
TP53 P04637 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
PKM P14618 1/20 0.59
HPGD P15428 1/20 0.59
ALOX15 P16050 1/20 0.59
CYP2C19 P33261 1/20 0.59
THPO P40225 1/20 0.59
KMT2A Q03164 1/20 0.59
GRIN2B Q13224 1/20 0.59
GRM1 Q13255 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17066360 0.75 NOS3 (0.43) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL29355216 0.74 GRM5 (1.00) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL103061 0.74 GRM5 (1.00) GRM5NPC1RAB9ASMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL29394034 0.73 NPC1 (1.00) GRM5NPC1RAB9ASMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL660360 0.73 NPC1 (1.00) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL7661794 0.72 GRM5 (0.68) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL5778843 0.71 GRM5 (0.62) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL30833070 0.69 GRM5 (0.54) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL3955825 0.69 GRM5 (0.54) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL701812 0.69 NOS3 (0.44) KDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 GRM5 1163/4885NPC1 3253/4885RAB9A 3911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.